Effects of an immunosuppressive therapy on the efficacy of immune checkpoint inhibition in metastatic melanoma - An analysis of the prospective skin cancer registry ADOREG.

Autor: Kochanek C; Department of Dermatology, Allergology and Venerology, Skin Cancer Centre, Hannover Medical School, Hannover, Germany. Electronic address: Kochanek.Corinna@mh-hannover.de., Gilde C; Department of Dermatology, Allergology and Venerology, Skin Cancer Centre, Hannover Medical School, Hannover, Germany., Zimmer L; Department of Dermatology, Venerology and Allergology, University Hospital Essen & Westdeutsches Tumorzentrum, Essen, Germany., Ugurel S; Department of Dermatology, Venerology and Allergology, University Hospital Essen & Westdeutsches Tumorzentrum, Essen, Germany; German Cancer Consortium (DKTK), partner site Essen/Düsseldorf, Germany., Meier F; Department of Dermatology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany; Skin Cancer Center at the University Cancer Centre Dresden and National Center for Tumor Diseases, Dresden, Germany., Utikal J; Skin Cancer Unit, German Cancer Research Center (DKFZ), Heidelberg, Germany; Department of Dermatology, Venerology and Allergology, University Medical Center Mannheim, Ruprecht-Karl University of Heidelberg, Mannheim, Germany; DKFZ Hector CancerInstitute at the University Medical Center Mannheim, Mannheim, Germany., Pföhler C; Department of Dermatology, Venerology and Allergology, Skin Cancer Centre, Saarland University Medical School, Homburg, Saar, Germany., Herbst R; Department of Dermatology and Allergology, Skin Cancer Centre, Helios Clinic Erfurt, Erfurt, Germany., Haferkamp S; Department of Dermatology, Skin Cancer Centre, University Hospital Regensburg, Regensburg, Germany., Welzel J; Department of Dermatology and Allergology, Skin Cancer Centre, Augsburg University Hospital, Augsburg, Germany., Dücker P; Department of Dermatology, Skin Cancer Centre, Hospital Dortmund, Dortmund, Germany., Leiter U; Centre of Dermatooncology, Department of Dermatology, Venerology and Allergology, University of Tuebingen, Germany., Weichenthal M; Department of Dermatology, Venerology and Allergology, Skin Cancer Centre, University Hospital of Schleswig-Holstein, Campus Kiel, Kiel, Germany., von Wasielewski I; Department of Dermatology, Allergology and Venerology, Skin Cancer Centre, Hannover Medical School, Hannover, Germany., Angela Y; Department of Dermatology, Johannes Wesling Medical Center Minden, Ruhr University Bochum Campus Minden, Minden, Germany., Gutzmer R; Department of Dermatology, Johannes Wesling Medical Center Minden, Ruhr University Bochum Campus Minden, Minden, Germany.

Publikováno v: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2024 Feb; Vol. 198, pp. 113508. Date of Electronic Publication: 2023 Dec 28.

1124P Adjuvant treatment of patients with stage III melanoma: 4-year follow-up time of multicenter real-world study

Autor: Livingstone, E., Forschner, A., Hassel, J.C., von Wasielewski, I., Meier, F., Mohr, P., Kähler, K.C., Schilling, B., Erdmann, M., Berking, C., Huning, S., Stege, H., Gutzmer, R., Kowall, B., Stang, A., Galetzka, W., Hauschild, A., Zimmer, L., Schadendorf, D., Lodde, G.C.

Publikováno v: In Annals of Oncology September 2024 35 Supplement 2:S740-S740

1093P Preliminary biomarker analysis in the phase III PIVOTAL study: Evidence for the mechanism of action of daromun in melanoma

Autor: Ascierto, P.A., Ziemer, M., Hassel, J.C., Rutkowski, P., Meier, F., Flatz, L., Gaudy Marqueste, C., Santinami, M., Russano, F., von Wasielewski, I., Eigentler, T.K., Maio, M., Zalaudek, I., Haferkamp, S., Quaglino, P., Garbe, C., Kähler, K.C., Robert, C., Hauschild, A., Schadendorf, D.

Publikováno v: In Annals of Oncology September 2024 35 Supplement 2:S724-S725

Treatment management for BRAF -mutant melanoma patients with tumor recurrence on adjuvant therapy: a multicenter study from the prospective skin cancer registry ADOREG.

Autor: Haist M; Department of Dermatology, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany Maximilian.Haist@unimedizin-mainz.de.; Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, California, USA., Stege H; Department of Dermatology, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany., Rogall F; Department of Dermatology, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany., Tan Y; Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, California, USA., von Wasielewski I; Skin Cancer Center Hannover, Department of Dermatology and Allergy, Hannover Medical School, Hannover, Germany., Klespe KC; Skin Cancer Center Hannover, Department of Dermatology and Allergy, Hannover Medical School, Hannover, Germany., Meier F; Department of Dermatology, University Hospital Carl Gustav Carus, Dresden, Germany.; Skin Cancer Center, National Center for Tumor Diseases, Dresden, Germany., Mohr P; Department of Dermatology, Elbe Kliniken Buxtehude, Buxtehude, Germany., Kähler KC; Department of Dermatology, Skin Cancer Center, University Hospital Schleswig-Holstein - Campus Kiel, Kiel, Germany., Weichenthal M; Department of Dermatology, Skin Cancer Center, University Hospital Schleswig-Holstein - Campus Kiel, Kiel, Germany., Hauschild A; Department of Dermatology, Skin Cancer Center, University Hospital Schleswig-Holstein - Campus Kiel, Kiel, Germany., Schadendorf D; Department of Dermatology, Venerology and Allergology, University Hospital Essen and German Cancer Consortium (DKTK), Partner Site Essen/Düsseldorf, Essen, Germany., Ugurel S; Department of Dermatology, Venerology and Allergology, University Hospital Essen and German Cancer Consortium (DKTK), Partner Site Essen/Düsseldorf, Essen, Germany., Lodde G; Department of Dermatology, Venerology and Allergology, University Hospital Essen and German Cancer Consortium (DKTK), Partner Site Essen/Düsseldorf, Essen, Germany., Zimmer L; Department of Dermatology, Venerology and Allergology, University Hospital Essen and German Cancer Consortium (DKTK), Partner Site Essen/Düsseldorf, Essen, Germany., Gutzmer R; Department of Dermatology, Muelenkreiskliniken Minden and Ruhr University Bochum, Minden, Germany., Debus D; Department of Dermatology, Nuremberg Hospital, Nurnberg, Germany., Schilling B; Department of Dermatology, University Hospital Würzburg, Würzburg, Germany., Kreuter A; Department of Dermatology, Venerology and Allergology, Helios St. Elisabeth Klinik Oberhausen, University Witten-Herdecke, Oberhausen, Germany., Ulrich J; Department of Dermatology and Allergy, Harzklinikum Dorothea Christiane Erxleben GmbH, Quedlinburg, Germany., Meiss F; Department of Dermatology and Venerology, Medical Center - University of Freiburg, Faculty of Medicine, Freiburg, Germany., Herbst R; Department of Dermatology, HELIOS Hospital Erfurt, Erfurt, Germany., Forschner A; Center for Dermatooncology, Department of Dermatology, Eberhard-Karls University of Tübingen, Tubingen, Germany., Leiter U; Center for Dermatooncology, Department of Dermatology, Eberhard-Karls University of Tübingen, Tubingen, Germany., Pfoehler C; Department of Dermatology, Saarland University Hospital and Saarland University Faculty of Medicine, Homburg, Germany., Kaatz M; Department of Dermatology, DRK Hospital Chemnitz-Rabenstein, Rabenstein, Germany., Ziller F; Department of Dermatology, DRK Hospital Chemnitz-Rabenstein, Chemnitz, Germany., Hassel JC; National Center for Tumor Diseases (NCT), Department of Dermatology, University Hospital Heidelberg, Heidelberg, Germany., Tronnier M; Department of Dermatology, HELIOS Hospital Hildesheim, Hildesheim, Germany., Sachse M; Department of Dermatology, Hospital Bremerhaven Reinkenheide, Bremerhaven, Germany., Dippel E; Department of Dermatology, Ludwigshafen City Hospital, Ludwigshafen, Germany., Terheyden P; Department of Dermatology, Allergology and Venerology, University Medical Center Schleswig Holstein Lübeck Campus, Lubeck, Germany., Berking C; Department of Dermatology, Uniklinikum Erlangen, Friedrich-Alexander University Erlangen-Nürnberg (FAU), Erlangen, Germany.; Comprehensive Cancer Center, Uniklinikum Erlangen, Friedrich-Alexander University Erlangen-Nürnberg (FAU), Erlangen, Germany., Heppt MV; Department of Dermatology, Uniklinikum Erlangen, Friedrich-Alexander University Erlangen-Nürnberg (FAU), Erlangen, Germany.; Comprehensive Cancer Center, Uniklinikum Erlangen, Friedrich-Alexander University Erlangen-Nürnberg (FAU), Erlangen, Germany., Kiecker F; Department of Dermatology, Vivantes Hospital Neukölln, Berlin, Germany., Haferkamp S; Department of Dermatology, University Hospital Regensburg, Regensburg, Germany., Gebhardt C; Department of Dermatology and Venerology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Simon JC; Department of Dermatology, University Hospital Leipzig, Leipzig, Germany., Grabbe S; Department of Dermatology, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany., Loquai C; Department of Dermatology, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.; Department of Dermatology, Gesundheit-Nord Hospital, Bremen, Germany.

Publikováno v: Journal for immunotherapy of cancer [J Immunother Cancer] 2023 Sep; Vol. 11 (9).

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.